Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Principia Biopharma Inc. (PRNB)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Principia Biopharma Inc. since year 2005.
Table 2 shows the detailed insider transactions of Principia Biopharma Inc. since 2005.
The reporting company's ticker symbol is PRNB. The reporting company's CIK number is 1510487.
The total value of stock buying since 2005 is $67,753,014.
The total value of stock sales since 2005 is $41,073,910.
The total value of stock option exercises since 2005 is $18,620.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-11-07||Goldstein David (Chief Scientific Officer)||Sale||10,000||32.39||323,910|
|2019-11-07||Goldstein David (Chief Scientific Officer)||Option Ex||10,000||1.86||18,620|
|2019-10-29||Becker Daniel J. (Director)||Buy||9,196||33.98||312,480|
|2019-10-28||Becker Daniel J. (Director)||Buy||68,404||33.41||2,285,582|
|2019-10-18||Becker Daniel J. (Director)||Buy||535,000||28.00||14,980,000|
|2019-10-18||George Simeon (Director)||Buy||357,142||28.00||9,999,976|
|2019-08-13||New Leaf Bpo Management Ii, L.l.c (10% Owner)||Sale||300,000||35.00||10,500,000|
|2019-05-21||Orbimed Capital Gp Iv Llc||Sale||1,000,000||30.25||30,250,000|
|2018-09-18||Becker Daniel J. (Director)||Buy||270,000||17.00||4,590,000|
|2018-09-18||New Leaf Bpo Management Ii, L.l.c (10% Owner)||Buy||270,000||17.00||4,590,000|
|2018-09-18||George Simeon (Director)||Buy||270,000||17.00||4,590,000|
|2018-09-18||Mehra Anand (10% Owner)||Buy||270,000||17.00||4,590,000|
|2018-09-18||Orbimed Capital Gp Iv Llc (10% Owner)||Buy||250,000||17.00||4,250,000|
|2018-09-18||Akkaraju Srinivas (Director)||Buy||175,000||17.00||2,975,000|
Insider trading activities including stock purchases, stock sales, and option exercises of PRNB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Principia Biopharma Inc. (symbol PRNB, CIK number 1510487) see the Securities and Exchange Commission (SEC) website.